Efficacy and safety of CT-P6 versus reference trastuzumab in HER2-positive early breast cancer: updated results of a randomised phase 3 trial
Titel:
Efficacy and safety of CT-P6 versus reference trastuzumab in HER2-positive early breast cancer: updated results of a randomised phase 3 trial
Auteur:
Esteva, F. J. Baranau, Y. V. Baryash, V. Manikhas, A. Moiseyenko, V. Dzagnidze, G. Zhavrid, E. Boliukh, D. Stroyakovskiy, D. Pikiel, J. Eniu, A. E. Li, R. K. Rusyn, A. V. Tiangco, B. Lee, S. J. Lee, S. Young Yu, S. Y. Stebbing, J.